Elos Medtech AB – earlier release of Q3 2017 report
Elos Medtech AB announces that the release of the interim report for the 3rd quarter 2017 is moved from October 27th to October 24th.
Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, such as dental and orthopedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.
Elos Medtech Group’s turnover is approximately MSEK 560 and has about 520 employees. The Group has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.
Gothenburg, August 30 2017
Elos Medtech AB (publ)
For further information, please contact:
Jan Wahlström, CEO, 46 70 212 18 89, e-mail: email@example.com
Christian Bergaust, CFO, 46 70 293 50 40, e-mail: firstname.lastname@example.org
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on August 30, 2017, at 19:00 (CET).